Search Results - "Ferenci, Peter"

Treatment of hepatitis C in difficult-to-treat patients by Ferenci, Peter

“…Key Points The availability of potent and safe direct-acting antiviral agents has substantially improved the treatment of chronic hepatitis C Patients who are…”
Get full text

Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver by Vilstrup, Hendrik, Amodio, Piero, Bajaj, Jasmohan, Cordoba, Juan, Ferenci, Peter, Mullen, Kevin D., Weissenborn, Karin, Wong, Philip

Get full text

Transplantation of hepatitis D virus patients: Lifelong hepatitis B immunoglobulins? by Ferenci, Peter, Reiberger, Thomas, Stadlbauer, Vanessa, Zoller, Heinz

“…The introduction of Hepatitis B Immunoglobulins (HBIg) prophylaxis at and after liver transplantation (LT) facilitated excellent long‐term survival of…”
Get full text

Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension by Mandorfer, Mattias, Kozbial, Karin, Schwabl, Philipp, Freissmuth, Clarissa, Schwarzer, Rémy, Stern, Rafael, Chromy, David, Stättermayer, Albert Friedrich, Reiberger, Thomas, Beinhardt, Sandra, Sieghart, Wolfgang, Trauner, Michael, Hofer, Harald, Ferlitsch, Arnulf, Ferenci, Peter, Peck-Radosavljevic, Markus

“…Graphical abstract…”
Get full text

Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon‐Free Therapy by Mandorfer, Mattias, Kozbial, Karin, Schwabl, Philipp, Chromy, David, Semmler, Georg, Stättermayer, Albert F., Pinter, Matthias, Hernández‐Gea, Virginia, Fritzer‐Szekeres, Monika, Steindl‐Munda, Petra, Trauner, Michael, Peck‐Radosavljevic, Markus, García‐Pagán, Juan C., Ferenci, Peter, Reiberger, Thomas

“…Background and Aims Sustained virologic response (SVR) to interferon (IFN)‐free therapies ameliorates portal hypertension (PH); however, it remains unclear…”
Get full text

Hepatoprotective and antiviral functions of silymarin components in hepatitis C virus infection by Polyak, Stephen J., Ferenci, Peter, Pawlotsky, Jean‐Michel

Get full text

MAFLD considerations as a part of the global hepatitis C elimination effort: an international perspective by Fouad, Yasser, Lazarus, Jeffrey V., Negro, Francesco, Peck‐Radosavljevic, Markus, Sarin, Shiv K., Ferenci, Peter, Esmat, Gamal, Ghazinian, Hasmik, Nakajima, Atsushi, Silva, Marcelo, Lee, Samuel, Colombo, Massimo

“…Summary Background The World Health Organization (WHO) set a goal to eliminate hepatitis C (HCV) infection globally by 2030, with specific targets to reduce…”
Get full text

Treatment of Chronic Hepatitis D with Bulevirtide-A Fight against Two Foes-An Update by Ferenci, Peter, Reiberger, Thomas, Jachs, Mathias

“…HDV infection frequently causes progression to cirrhosis and hepatocellular carcinoma (HCC). In summer 2020, the first potentially effective drug Bulevirtide…”
Get full text

Experimental models of hepatic encephalopathy: ISHEN guidelines by Butterworth, Roger F., Norenberg, Michael D., Felipo, Vicente, Ferenci, Peter, Albrecht, Jan, Blei, Andres T.

“…Objectives of the International Society for Hepatic Encephalopathy and Nitrogen Metabolism Commission were to identify well‐characterized animal models of…”
Get full text

The dilemma to diagnose Wilson disease by genetic testing alone by Stättermayer, Albert Friedrich, Entenmann, Andreas, Gschwantler, Michael, Zoller, Heinz, Hofer, Harald, Ferenci, Peter

“…Background Wilson disease (WD) is an autosomal recessive disorder of hepatic copper excretion. About sixty per cent of patients present with liver disease. WD…”
Get full text

Hepatic steatosis in Wilson disease – Role of copper and PNPLA3 mutations by Stättermayer, Albert Friedrich, Traussnigg, Stefan, Dienes, Hans-Peter, Aigner, Elmar, Stauber, Rudolf, Lackner, Karoline, Hofer, Harald, Stift, Judith, Wrba, Friedrich, Stadlmayr, Andreas, Datz, Christian, Strasser, Michael, Maieron, Andreas, Trauner, Michael, Ferenci, Peter

“…Background & Aims The earliest characteristic alterations of the liver pathology in Wilson disease (WD) include steatosis, which is sometimes indistinguishable…”
Get full text

Response guided therapy in patients with chronic hepatitis C – Yesterday, today and tomorrow by Ferenci, Peter, MD

“…Abstract The rapidity of viral disappearance on antiviral treatment of chronic hepatitis C with peginterferon/ribavirin correlates with the cure rate. The…”
Get full text

Early on‐treatment prediction of response to peginterferon alfa‐2a for HBeAg‐negative chronic hepatitis B using HBsAg and HBV DNA levels by Rijckborst, Vincent, Hansen, Bettina E., Cakaloglu, Yilmaz, Ferenci, Peter, Tabak, Fehmi, Akdogan, Meral, Simon, Krzysztof, Akarca, Ulus S., Flisiak, Robert, Verhey, Elke, Van Vuuren, Anneke J., Boucher, Charles A. B., ter Borg, Martijn J., Janssen, Harry L. A.

“…Peginterferon alfa‐2a results in a sustained response (SR) in a minority of patients with hepatitis B e antigen (HBeAg)–negative chronic hepatitis B (CHB)…”
Get full text

Predictors of response to therapy for chronic hepatitis C by Ferenci, Peter

“…Pretreatment prediction of successful interferon-based therapy is less accurate than is prediction based on serum hepatitis C virus (HCV) RNA measurements…”
Get more information

Hepatic encephalopathy—Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998 by Ferenci, Peter, Lockwood, Alan, Mullen, Kevin, Tarter, Ralph, Weissenborn, Karin, Blei, Andres T.

“…Research on hepatic encephalopathy is hampered by the imprecise definition of this disabling complication of liver disease. Under this light, the Organisation…”
Get full text

Effect of IL28B genotype on hepatitis B and C virus infection by Stättermayer, Albert Friedrich, Ferenci, Peter

“…•IL28B polymorphism is strongly associated with IFN-induced viral clearance in chronic HCV infection.•IL28B polymorphism is strongly associated with…”
Get full text

Pathophysiology and clinical features of Wilson disease by Ferenci, Peter

“…Wilson disease is an autosomal recessive inherited disorder of copper metabolism resulting in pathological accumulation of copper in many organs and tissues…”
Get full text

Hepatic manifestations of Wilson's disease: 12-year experience in a Swiss tertiary referral centre by Vieira Barbosa, Joana, Fraga, Montserrat, Saldarriaga, Joan, Hiroz, Philippe, Giostra, Emiliano, Sempoux, Christine, Ferenci, Peter, Moradpour, Darius

“…Wilson's disease is an inherited disorder of hepatic copper metabolism, leading to the accumulation of copper in the liver as well as the brain, cornea and…”
Get full text

Long-term follow-up of Wilson Disease: natural history, treatment, mutations analysis and phenotypic correlation by Bruha, Radan, Marecek, Zdenek, Pospisilova, Lenka, Nevsimalova, Sona, Vitek, Libor, Martasek, Pavel, Nevoral, Jiri, Petrtyl, Jaromir, Urbanek, Petr, Jiraskova, Alena, Ferenci, Peter

“…Background and aims: Wilson disease (WD) is an inherited disorder of copper metabolism. When treated, the outcome can be excellent, although the long‐term…”
Get full text

Serum Level of IP-10 Increases Predictive Value of IL28B Polymorphisms for Spontaneous Clearance of Acute HCV Infection by Beinhardt, Sandra, Aberle, Judith H, Strasser, Michael, Dulic–Lakovic, Emina, Maieron, Andreas, Kreil, Anna, Rutter, Karoline, Staettermayer, Albert F, Datz, Christian, Scherzer, Thomas M, Strassl, Robert, Bischof, Martin, Stauber, Rudolf, Bodlaj, Gerd, Laferl, Hermann, Holzmann, Heidemarie, Steindl–Munda, Petra, Ferenci, Peter, Hofer, Harald

“…Background & Aims Single nucleotide polymorphisms (SNPs) in IL28B and serum levels of interferon γ inducible protein 10 (IP-10) predict outcomes of antiviral…”
Get full text